Daily Sepsis Research Analysis
Analyzed 49 papers and selected 3 impactful papers.
Summary
Analyzed 49 papers and selected 3 impactful articles.
Selected Articles
1. On the inevitability of microvascular failure in septic shock and other vasodilatory conditions.
A large-scale computational model shows that in septic vasodilation, the cardiac output required to maintain endothelial shear rises with the cube of arteriolar radii; when unmet, vessels derecruit, producing heterogeneous perfusion and reduced functional capillary density. This framework reproduces hallmark septic microvascular phenomena and predicts that reducing global vasodilation or the apparent endothelial shear target may restore coherence without supranormal cardiac output.
Impact: Provides a mechanistic, testable unifying model for hemodynamic incoherence in septic shock, bridging micro- and macro-circulatory physiology and generating therapeutic hypotheses.
Clinical Implications: Suggests reinterpreting hemodynamic targets beyond blood pressure, focusing on interventions that reduce global vasodilation or modulate endothelial shear sensing to restore microvascular coherence.
Key Findings
- A 1,000,000-arteriole network model with an apparent endothelial shear target shows total flow demand scales with the sum of vessel radii cubed.
- Unmet flow demand leads to low-shear functional derecruitment, heterogeneous perfusion, and reduced functional capillary density.
- The model reproduces hyperdynamic circulation and microvascular shunting seen in severe sepsis.
- Therapies that reduce global vasodilation or lower the apparent shear target may restore microvascular coherence without requiring supranormal cardiac output.
Methodological Strengths
- Mechanistic computational modeling grounded in physiologically plausible vessel-radius distributions and endothelial shear sensing.
- Generates quantitative, testable predictions linking microvascular behavior to macrocirculatory demands.
Limitations
- Conceptual model without prospective clinical or in vivo experimental validation.
- Assumptions about endothelial shear targets and parameterization may not generalize across patient states.
Future Directions: Validate model predictions with bedside microcirculatory imaging and interventional studies that modulate vasodilation or endothelial shear sensing; integrate patient-specific parameters for precision hemodynamics.
Microcirculatory dysfunction is a defining feature of septic shock and is strongly associated with mortality, yet its relationship to macrocirculatory haemodynamics remains poorly understood. In particular, the persistence of heterogeneous capillary perfusion despite restoration of blood pressure and cardiac output (termed haemodynamic incoherence) lacks a coherent mechanistic explanation. I developed a conceptual and computational model of the microcirculation in which network behaviour is constrained by three interacting variables: cardiac output, vasomotor state, and shear stress regulation. A network of one million parallel arterioles was simulated using physiologically plausible distributions of vessel radius. For each vessel, flow requirements were determined by an apparent shear target, reflecting endothelial sensing of shear rather than absolute physical values. Total cardiac output required to maintain network-wide shear was calculated as the sum of individual vessel demands. The model demonstrates that, for a given shear target, total flow requirements increase in proportion to the sum of vessel radii cubed, such that even modest global vasodilation produces a substantial increase in required cardiac output. Increasing the apparent shear target further amplifies this demand. When cardiac output is insufficient to meet these requirements, vessels experience low shear and undergo functional derecruitment, reducing total flow demand but resulting in marked heterogeneity and reduced functional capillary density. These behaviours reproduce key features of septic physiology, including the hyperdynamic circulation and microvascular shunting observed in severe sepsis. The model provides a unifying framework in which microcirculatory dysfunction emerges as an inevitable consequence of the interaction between vasodilation, flow limitation, and shear regulation, rather than as an independent pathological process. It further predicts that therapies which reduce global vasodilation or lower the apparent shear target may restore microvascular coherence without requiring supranormal cardiac output. This framework generates testable hypotheses and offers a physiologically grounded basis for reinterpreting haemodynamic management in septic shock.
2. Medical Record Abstraction for Quality Improvement in Sepsis Care Using Artificial Intelligence: A Cluster Randomized Trial.
In a single-blind cluster randomized trial across two EDs (66 physicians; 301 eligible patients), LLM-enabled, near–real-time feedback increased SEP-1 compliance by 13% absolute (OR 2.10; P=0.02) versus usual practice, with 92% agreement to expert review. Improvements were driven by documentation-sensitive components (30 mL/kg fluids), without changes in ICU admissions or 30-day mortality.
Impact: Demonstrates pragmatic, randomized evidence that AI can improve a national sepsis quality metric at the point of care, addressing a key barrier in quality reporting and clinical integration.
Clinical Implications: AI-enabled, real-time measurement and feedback can be integrated into ED workflows to improve bundle adherence; however, linkage to patient-centered outcomes will require larger, multi-site trials and attention to documentation-sensitive components.
Key Findings
- LLM-driven feedback increased overall SEP-1 compliance from 70.1% to 82.9% (absolute +13%; OR 2.10; P=0.02).
- The largest improvement was in the 30 mL/kg fluid bolus component (1.7% vs 13.2% noncompletion).
- LLM determinations agreed with expert adjudication in 92%, with no differences in ICU admission or 30-day mortality.
Methodological Strengths
- Single-blind, cluster randomized design with trial registration and mixed-effects modeling.
- Real-time implementation embedded in routine ED practice with physician-level randomization.
Limitations
- Conducted within a single health system (2 EDs) with modest patient numbers.
- Observed gains were greatest in documentation-sensitive components; no mortality effect detected.
Future Directions: Scale to multi-system trials to assess generalizability, optimize human-AI workflows, and power for patient-centered outcomes; evaluate fairness, safety, and auditability.
IMPORTANCE: Hospital quality reporting remains a manual, costly process with critical limitations as a mechanism to improve care outcomes. OBJECTIVE: To assess whether near-real-time quality measurement, enabled by large language models (LLMs), can improve quality performance as measured by the Centers for Medicare & Medicaid Services (CMS) Severe Sepsis and Septic Shock Management Bundle (SEP-1) quality metric. DESIGN, SETTING, AND PARTICIPANTS: This single-blind, unstratified, cluster randomized trial was conducted between December 13, 2024, and July 8, 2025, at 2 academic emergency departments (EDs) within the University of California, San Diego (UCSD) health system. Participants included all 66 attending physicians who practiced in the UCSD EDs and worked more than 3 shifts per month prior to study initiation. INTERVENTION: Participants were randomized to receive targeted feedback from LLM-determined compliance with SEP-1 at the time of patient discharge or standard process. MAIN OUTCOMES AND MEASURES: The primary outcome was overall compliance with SEP-1. Secondary outcomes included expert agreement with the LLM SEP-1 determination, 30-day mortality, and intensive care unit admissions of patients with severe sepsis and/or septic shock in the ED. Effect sizes were estimated from a mixed-effects logistic regression model with the intervention group as a fixed effect and a random intercept for physician. RESULTS: The study population included 66 physicians who treated 301 patients (121 in the control group and 180 in the intervention group; median age, 64.3 [IQR, 51.1-75.7] years; 171 [56.8%] male; 52 [17.3%] with chronic kidney disease; 52 [17.3%] with chronic heart failure) who met CMS inclusion criteria for SEP-1. Physicians in the control group had a SEP-1 compliance rate of 70.1%, while those in the intervention group had a rate of 82.9%. Assignment to the intervention group resulted in a 13.0% absolute improvement in SEP-1 compliance (95% CI, 2.5%-23.4%; odds ratio, 2.10 [95% CI, 1.15-3.81]; P = .02) in the mixed-effects model. The largest difference between the intervention group and control group was in noncompletion of the 30-mL/kg fluid bolus component (3 of 180 [1.7%] vs 16 of 121 [13.2%]), a documentation-sensitive component of the quality measure. Agreement between LLM determination and expert review was 92%. No significant differences existed in intensive care unit admissions or 30-day mortality. CONCLUSIONS AND RELEVANCE: In this cluster randomized trial of artificial intelligence (AI)-enabled medical record abstraction for sepsis care, rapid assessment of SEP-1 performance and targeted feedback improved overall compliance with the measure. AI-driven quality clinical integration may address limitations in existing hospital quality reporting and better support a learning health system. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT07581340.
3. An interpretable prediction model for severe sepsis-associated acute kidney injury in older ICU patients with sepsis: a prospective multicenter cohort study.
A 7-variable, interpretable nomogram integrating clinical and immune-inflammatory markers (nonrenal SOFA, CKD, lactate, IL-6, NK%, CD4% T cells, C3) achieved AUCs of 0.917 (training) and 0.904 (temporal validation) to predict KDIGO stage 2–3 SA-AKI within 7 days in 1,236 older septic ICU patients. Severe SA-AKI risk rose from 0.5% to 77.5% across low-to-high risk groups.
Impact: Offers a parsimonious, interpretable, prospectively derived risk tool that integrates immune profiling, enabling early prevention strategies for severe SA-AKI in a high-risk geriatric population.
Clinical Implications: Supports early risk stratification to prioritize nephroprotective measures, guide fluid/vasopressor strategies, and allocate monitoring resources; requires external validation for broader adoption.
Key Findings
- A 7-variable model (nonrenal SOFA, CKD, log-lactate, log-IL-6, NK%, CD4% T cells, C3) predicted severe SA-AKI with AUCs of 0.917 and 0.904.
- Brier scores were low (0.086 and 0.096), indicating good calibration.
- Risk stratification showed severe SA-AKI incidence of 0.5%, 13.0%, and 77.5% in low-, intermediate-, and high-risk groups.
Methodological Strengths
- Prospective multicenter design with temporal internal validation.
- Interpretable logistic nomogram integrating clinical and immune-inflammatory markers.
Limitations
- No external, geographic validation; generalizability remains to be established.
- Biomarker availability (e.g., IL-6, immune subsets) may limit immediate bedside implementation.
Future Directions: External, multi-ethnic validation; evaluation of impact on kidney-protective decision-making and outcomes; integration into EHRs for real-time clinical decision support.
BACKGROUND: Severe sepsis-associated acute kidney injury (severe SA-AKI) is clinically important in older adults with sepsis, but early identification remains challenging. This study aimed to characterize clinical and immuno-inflammatory features of severe SA-AKI and develop an interpretable prediction model for older ICU patients with sepsis. METHODS: This prospective multicenter cohort study enrolled older adults with sepsis admitted to five tertiary ICUs between June 2023 and December 2025. Patients were temporally assigned to a training cohort and an internal temporal validation cohort. Severe SA-AKI was defined as KDIGO acute kidney injury stage 2 or 3 within 7 days after sepsis time zero or during ICU stay. Candidate predictors collected within 24 h after time zero were evaluated in the training cohort, and a logistic regression nomogram was developed and validated. RESULTS: Among 1,236 included patients, the minimum age was 65 years, and the mean age was 74.6 ± 7.5 years; 258 patients developed severe SA-AKI. The final 7-variable model included non-renal SOFA score, chronic kidney disease, log(Lactate + 1), log(IL-6 + 1), NK-cell percentage, CD4 + T-cell percentage, and C3. The model achieved AUCs of 0.917 and 0.904 in the training and validation cohorts, respectively. Brier scores were 0.086 and 0.096. Severe SA-AKI incidence increased across low-, intermediate-, and high-risk groups: 0.5%, 13.0%, and 77.5%. CONCLUSIONS: A parsimonious model integrating clinical and immuno-inflammatory variables may support early severe SA-AKI risk stratification in older ICU patients with sepsis. External validation is warranted before broader clinical implementation.